ESR1 and breast cancer: A series of studies indicated that melatonin suppressed ERα mRNA expression, inhibited p38 MAPK signaling, repressed epithelial-to-mesenchymal transition, and correlated with intrinsic resistance to tamoxifen and doxorubicin in estrogen receptor alpha (ERα)-positive human breast cancer [11, 12].